Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saul M Genuth

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Preventive Medicine|September 22, 2014
Self-reported prevalence of diabetes screening in the U.S., 2005-2010Sarah Stark Casagrande, Catherine C Cowie, Saul M Genuth
BMJ Open Diabetes Research & Care|January 21, 2022
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDICVincent M Monnier, David R Sell, Xiaoyu Gao, et al.
The New England Journal of Medicine|December 24, 2005
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesDavid M Nathan, Patricia A Cleary, Jye-Yu C Backlund, et al.
Diabetes|June 14, 2013
Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyTrevor J Orchard, Wanjie Sun, Patricia A Cleary, et al.
Diabetes|March 23, 2013
Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDICSaul M Genuth, Jye-Yu C Backlund, Margaret Bayless, et al.
Mayo Clinic Proceedings|October 9, 2019
BARI 2D: A Reanalysis Focusing on Cardiovascular EventsSaul M Genuth, Helen Vlachos, Maria Mori Brooks, et al.
The New England Journal of Medicine|June 9, 2009
A randomized trial of therapies for type 2 diabetes and coronary artery disease, Robert L Frye, Phyllis August, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Preventive Medicine|September 22, 2014
Self-reported prevalence of diabetes screening in the U.S., 2005-2010Sarah Stark Casagrande, Catherine C Cowie, Saul M Genuth
BMJ Open Diabetes Research & Care|January 21, 2022
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDICVincent M Monnier, David R Sell, Xiaoyu Gao, et al.
The New England Journal of Medicine|December 24, 2005
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesDavid M Nathan, Patricia A Cleary, Jye-Yu C Backlund, et al.
Diabetes|June 14, 2013
Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyTrevor J Orchard, Wanjie Sun, Patricia A Cleary, et al.
Diabetes|March 23, 2013
Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDICSaul M Genuth, Jye-Yu C Backlund, Margaret Bayless, et al.
Mayo Clinic Proceedings|October 9, 2019
BARI 2D: A Reanalysis Focusing on Cardiovascular EventsSaul M Genuth, Helen Vlachos, Maria Mori Brooks, et al.
The New England Journal of Medicine|June 9, 2009
A randomized trial of therapies for type 2 diabetes and coronary artery disease, Robert L Frye, Phyllis August, et al.
Pageof 1